- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 55.15M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $30.46M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $39.84M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $90.24M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $202.02M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $633.17M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $603.89M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $2.01B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $2.01B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 57.66M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $4.29M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $36.57M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $1.49B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $1.49B |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.26 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.26 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $8.17M |
| Net Income | Q1 2025 · Mar 31, 2024 | $14.98M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $5.55M |